from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit: us-gaap: shares
Description: The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary: ACCENDRA HEALTH INC/VA/ quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
ACCENDRA HEALTH INC/VA/ Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 76,897,000, a 0.2% increase year-over-year.
ACCENDRA HEALTH INC/VA/ annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 76,897,000, a 0.2% increase from 2024.
ACCENDRA HEALTH INC/VA/ annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 76,741,000, a 0.81% decline from 2023.
ACCENDRA HEALTH INC/VA/ annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 77,367,000, a 1.5% increase from 2022.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)

Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	76,897,000	+156,000	+0.2%	01 Oct 2025	31 Dec 2025	10-K	20 Feb 2026	2025	FY
Q3 2025	77,288,000	-1,188,000	-1.5%	01 Jul 2025	30 Sep 2025	10-Q	31 Oct 2025	2025	Q3
Q2 2025	76,935,000	+208,000	+0.27%	01 Apr 2025	30 Jun 2025	10-Q	11 Aug 2025	2025	Q2
Q1 2025	77,272,000	+953,000	+1.2%	01 Jan 2025	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	76,741,000	-626,000	-0.81%	01 Oct 2024	31 Dec 2024	10-K	20 Feb 2026	2025	FY
Q3 2024	78,476,000	+2,273,000	+3%	01 Jul 2024	30 Sep 2024	10-Q	31 Oct 2025	2025	Q3
Q2 2024	76,727,000	+926,000	+1.2%	01 Apr 2024	30 Jun 2024	10-Q	11 Aug 2025	2025	Q2
Q1 2024	76,319,000	+1,142,000	+1.5%	01 Jan 2024	31 Mar 2024	10-Q	08 May 2025	2025	Q1
Q4 2023	77,367,000	+1,150,000	+1.5%	01 Oct 2023	31 Dec 2023	10-K	20 Feb 2026	2025	FY
Q3 2023	76,203,000	-212,000	-0.28%	01 Jul 2023	30 Sep 2023	10-Q	04 Nov 2024	2024	Q3
Q2 2023	75,801,000	-496,000	-0.65%	01 Apr 2023	30 Jun 2023	10-Q	02 Aug 2024	2024	Q2
Q1 2023	75,177,000	-842,000	-1.1%	01 Jan 2023	31 Mar 2023	10-Q	03 May 2024	2024	Q1
Q4 2022	76,217,000	+731,000	+0.97%	01 Oct 2022	31 Dec 2022	10-K	28 Feb 2025	2024	FY
Q3 2022	76,415,000	+457,000	+0.6%	01 Jul 2022	30 Sep 2022	10-Q	03 Nov 2023	2023	Q3
Q2 2022	76,297,000	+492,000	+0.65%	01 Apr 2022	30 Jun 2022	10-Q	04 Aug 2023	2023	Q2
Q1 2022	76,019,000	+5,081,000	+7.2%	01 Jan 2022	31 Mar 2022	10-Q	05 May 2023	2023	Q1
Q4 2021	75,486,000	+11,974,000	+19%	01 Oct 2021	31 Dec 2021	10-K	20 Feb 2024	2023	FY
Q3 2021	75,958,000	+15,035,000	+25%	01 Jul 2021	30 Sep 2021	10-Q	02 Nov 2022	2022	Q3
Q2 2021	75,805,000	+14,677,000	+24%	01 Apr 2021	30 Jun 2021	10-Q	03 Aug 2022	2022	Q2
Q1 2021	70,938,000	+10,367,000	+17%	01 Jan 2021	31 Mar 2021	10-Q	04 May 2022	2022	Q1
Q4 2020	63,512,000			01 Oct 2020	31 Dec 2020	10-K	28 Feb 2023	2022	FY
Q3 2020	60,923,000	+893,000	+1.5%	01 Jul 2020	30 Sep 2020	10-Q	03 Nov 2021	2021	Q3
Q2 2020	61,128,000			01 Apr 2020	30 Jun 2020	10-Q	03 Aug 2021	2021	Q2
Q1 2020	60,571,000			01 Jan 2020	31 Mar 2020	10-Q	05 May 2021	2021	Q1
Q3 2019	60,030,000			01 Jul 2019	30 Sep 2019	10-Q	03 Nov 2020	2020	Q3
Q4 2016	61,093,000	-1,024,000	-1.6%	01 Oct 2016	31 Dec 2016	10-K	23 Feb 2018	2017	FY
Q3 2016	61,015,000	-983,000	-1.6%	01 Jul 2016	30 Sep 2016	10-Q	02 Nov 2016	2016	Q3
Q2 2016	61,502,000	-724,000	-1.2%	01 Apr 2016	30 Jun 2016	10-Q	03 Aug 2016	2016	Q2
Q1 2016	61,696,000	-570,000	-0.92%	01 Jan 2016	31 Mar 2016	10-Q	04 May 2016	2016	Q1
Q4 2015	62,117,000	-109,000	-0.18%	01 Oct 2015	31 Dec 2015	10-K	23 Feb 2018	2017	FY
Q3 2015	61,998,000	-181,000	-0.29%	01 Jul 2015	30 Sep 2015	10-Q	02 Nov 2016	2016	Q3
Q2 2015	62,226,000	-90,000	-0.14%	01 Apr 2015	30 Jun 2015	10-Q	03 Aug 2016	2016	Q2
Q1 2015	62,266,000	-51,000	-0.08%	01 Jan 2015	31 Mar 2015	10-Q	04 May 2016	2016	Q1
Q4 2014	62,226,000	-435,000	-0.69%	01 Oct 2014	31 Dec 2014	10-K	17 Feb 2017	2016	FY
Q3 2014	62,179,000	-452,000	-0.72%	01 Jul 2014	30 Sep 2014	10-Q	28 Oct 2015	2015	Q3
Q2 2014	62,316,000	-436,000	-0.7%	01 Apr 2014	30 Jun 2014	10-Q	28 Jul 2015	2015	Q2
Q1 2014	62,317,000	-428,000	-0.68%	01 Jan 2014	31 Mar 2014	10-Q	28 Apr 2015	2015	Q1
Q4 2013	62,661,000	-183,000	-0.29%	01 Oct 2013	31 Dec 2013	10-K	25 Feb 2016	2015	FY
Q3 2013	62,631,000	-210,000	-0.33%	01 Jul 2013	30 Sep 2013	10-Q	29 Oct 2014	2014	Q3
Q2 2013	62,752,000	-143,000	-0.23%	01 Apr 2013	30 Jun 2013	10-Q	30 Jul 2014	2014	Q2
Q1 2013	62,745,000	-156,000	-0.25%	01 Jan 2013	31 Mar 2013	10-Q	01 May 2014	2014	Q1
Q4 2012	62,844,000	-80,000	-0.13%	01 Oct 2012	31 Dec 2012	10-K	23 Feb 2015	2014	FY
Q3 2012	62,841,000	-106,000	-0.17%	01 Jul 2012	30 Sep 2012	10-Q	07 Nov 2013	2013	Q3
Q2 2012	62,895,000	-303,000	-0.48%	01 Apr 2012	30 Jun 2012	10-Q	02 Aug 2013	2013	Q2
Q1 2012	62,901,000	+40,000	+0.06%	01 Jan 2012	31 Mar 2012	10-Q	03 May 2013	2013	Q1
Q4 2011	62,924,000			01 Oct 2011	31 Dec 2011	10-K	25 Feb 2014	2013	FY
Q3 2011	62,947,000	+335,000	+0.54%	01 Jul 2011	30 Sep 2011	10-Q	02 Nov 2012	2012	Q3
Q2 2011	63,198,000	+592,000	+0.95%	01 Apr 2011	30 Jun 2011	10-Q	27 Jul 2012	2012	Q2
Q1 2011	62,861,000			01 Jan 2011	31 Mar 2011	10-Q	27 Apr 2012	2012	Q1
Q3 2010	62,612,000			01 Jul 2010	30 Sep 2010	10-Q	28 Oct 2011	2011	Q3
Q2 2010	62,606,000			01 Apr 2010	30 Jun 2010	10-Q	29 Jul 2011	2011	Q2

ACCENDRA HEALTH INC/VA/ Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	76,897,000	+156,000	+0.2%	01 Jan 2025	31 Dec 2025	10-K	20 Feb 2026	2025	FY
2024	76,741,000	-626,000	-0.81%	01 Jan 2024	31 Dec 2024	10-K	20 Feb 2026	2025	FY
2023	77,367,000	+1,150,000	+1.5%	01 Jan 2023	31 Dec 2023	10-K	20 Feb 2026	2025	FY
2022	76,217,000	+731,000	+0.97%	01 Jan 2022	31 Dec 2022	10-K	28 Feb 2025	2024	FY
2021	75,486,000	+11,974,000	+19%	01 Jan 2021	31 Dec 2021	10-K	20 Feb 2024	2023	FY
2020	63,512,000	+2,938,000	+4.8%	01 Jan 2020	31 Dec 2020	10-K	28 Feb 2023	2022	FY
2019	60,574,000			01 Jan 2019	31 Dec 2019	10-K	23 Feb 2022	2021	FY
2017	60,001,000	-1,092,000	-1.8%	01 Jan 2017	31 Dec 2017	10-K	23 Feb 2018	2017	FY
2016	61,093,000	-1,024,000	-1.6%	01 Jan 2016	31 Dec 2016	10-K	23 Feb 2018	2017	FY
2015	62,117,000	-109,000	-0.18%	01 Jan 2015	31 Dec 2015	10-K	23 Feb 2018	2017	FY
2014	62,226,000	-435,000	-0.69%	01 Jan 2014	31 Dec 2014	10-K	17 Feb 2017	2016	FY
2013	62,661,000	-183,000	-0.29%	01 Jan 2013	31 Dec 2013	10-K	25 Feb 2016	2015	FY
2012	62,844,000	-80,000	-0.13%	01 Jan 2012	31 Dec 2012	10-K	23 Feb 2015	2014	FY
2011	62,924,000	+361,000	+0.58%	01 Jan 2011	31 Dec 2011	10-K	25 Feb 2014	2013	FY
2010	62,563,000			01 Jan 2010	31 Dec 2010	10-K	22 Feb 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.